Poly(lactic‐co‐glycolic acid) devices: Production and applications for sustained protein delivery

Abstract

Injectable or implantable poly(lactic-co-glycolic acid) (PLGA) devices for the sustained delivery of proteins have been widely studied and utilized to overcome the necessity of repeated administrations for therapeutic proteins due to poor pharmacokinetic profiles of macromolecular therapies. These devices can come in the form of microparticles, implants, or patches depending on the disease state and route of administration. Furthermore, the release rate can be tuned from weeks to months by controlling the polymer composition, geometry of the device, or introducing additives during device fabrication. Slow-release devices have become a very powerful tool for modern medicine. Production of these devices has initially focused on emulsion-based methods, relying on phase separation to encapsulate proteins within polymeric microparticles. Process parameters and the effect of additives have been thoroughly researched to ensure protein stability during device manufacturing and to control the release profile. Continuous fluidic production methods have also been utilized to create protein-laden PLGA devices through spray drying and electrospray production. Thermal processing of PLGA with solid proteins is an emerging production method that allows for continuous, high-throughput manufacturing of PLGA/protein devices. Overall, polymeric materials for protein delivery remain an emerging field of research for the creation of single administration treatments for a wide variety of disease. This review describes, in detail, methods to make PLGA devices, comparing traditional emulsion-based methods to emerging methods to fabricate protein-laden devices. This article is categorized under: Biology-Inspired Nanomaterials > Protein and Virus-Based Structures Implantable Materials and Surgical Technologies > Nanomaterials and Implants Biology-Inspired Nanomaterials > Peptide-Based Structures.

Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery

“…Cells enzymatically degrade PLGA into monomers that can cause cell death due to their acidic nature [202]. PLGA can be formulated into scaffolds, nano and microparticles, and electrospun fibers [203]. The ability to create biocompatible scaffolds with tunable drug delivery properties makes PLGA an attractive material for stem cell-based tissue engineering.…”

Preparation and evaluation of amphipathic lipopeptide‐loaded PLGA microspheres as sustained‐release system for AIDS prevention

“…In the encapsulation of hydrophilic peptides or proteins, drug leakage from the internal water phase to the external water phase is a big challenge [23–27]. Fortunately, LP‐98 shows better encapsulation and drug loading efficiency, which was attributed to the amphiphilicity of lipopeptide.…”

Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment

“…The relatively high initial burst release of RDV from the gel depot can be directly linked to the fast sol–gel transition of the formulation. The quick gel formation process was driven by the rapid transfer of the water miscible organic solvent NMP from the solution formulation into the aqueous environment with a simultaneous rapid phase separation of PLGA polymer ( Ahmed et al, 2016 , Lee and Pokorski, 2018 ). This is followed by formation of large pores leading to the formation of water accessible channels on the surface and inner core.…”